FDA Approved: FOTIVDA — Supplemental Application (AVEO Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fotivda (tivozanib) submitted by AVEO Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• FOTIVDA (tivozanib)

Snippet

SUPPL AP for FOTIVDA (TIVOZANIB)